1. Home
  2. BLRX
  3. BLRX News

Latest BioLineRx Ltd. (BLRX) News on April 24, 2025

Zacks Small Cap Research

21 days ago

BLRX: 2024 Financial Results

BLRX: Aphexda Transition Progressing

Zacks Small Cap Research

2 months ago

BLRX: Aphexda Transition Progressing

BioLineRx Announces USPTO Allowance of New Composition of Matter Patent on Motixafortide

PR Newswire

6 months ago

BioLineRx Announces USPTO Allowance of New Composition of Matter Patent on Motixafortide

BLRX: On Track for 60% Formulary Placement

Zacks Small Cap Research

8 months ago

BLRX: On Track for 60% Formulary Placement

BLRX: First Quarter 2024 Results

Zacks Small Cap Research

10 months ago

BLRX: First Quarter 2024 Results

Business Wire

a year ago

Form 8.3 - Darktrace plc

Business Wire

a year ago

Form 8.3 - DS Smith plc

Zacks Small Cap Research

a year ago

BLRX: First Aphexda Sales Recognized

BLRX: Poster Presentations

Zacks Small Cap Research

a year ago

BLRX: Poster Presentations

Associated Press Finance

a year ago

BCB Bancorp: Q4 Earnings Snapshot

BLRX: A Series of Fortunate Events

Zacks Small Cap Research

a year ago

BLRX: A Series of Fortunate Events

Thomson Reuters StreetEvents

a year ago

Q3 2023 Acumen Pharmaceuticals Inc Earnings Call

Associated Press Finance

a year ago

Cross Timbers: Q3 Earnings Snapshot

Share on Social Networks: